Safety of off-label dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

Author

C. van den Dries

R. Pajouheshnia

H. van den Ham

P. Souverein

K. Moons

A. Hoes

G. Geersing

S. van Doorn

Keywords

anticoagulation

Atrial fibrillation

non-vitamin K antagonist oral anticoagulants

off-label dose reduction

Year of Publication

2022

Journal

Br J Clin Pharmacol

ISBN Number

0306-5251

Accession Number

36102068

DOI

10.1111/bcp.15534

• DOI
• Google Scholar
• BibTeX
• EndNote X3 XML
• EndNote 7 XML
• Endnote tagged
• Marc
• RIS